ArriVent
formerly ArriVent BioPharmaIPOHome - ArriVent BioPharma
Public · Newtown Square, United States · Founded 2021 · $305.0M raised
- Headquarters
- Newtown Square, Pennsylvania
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- arrivent.com
- Total Funding
- $305.0M
- Last Round
- $155.0M Series BMar 2023
- Rounds
- 2
- Type
- Public
About
ArriVent BioPharma was founded in 2021 to identify, develop, and commercialize differentiated medicines from around the world — particularly innovative therapies initially developed in China, Europe, South Korea, and Japan that might not otherwise reach global patients. The company applies deep oncology expertise and regulatory knowledge to in-license clinical-stage candidates with strong biological rationale and a clear path to approval.
Summary
ArriVent is a Biotech company based in Newtown Square, United States, founded in 2021. It has raised $305.0M in total across 2 rounds, most recently a $155.0M Series B round in Mar 2023. Investors include General Catalyst, Sofinnova Investments and Hillhouse Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2025
Sign up to see all 5 rounds
Series A through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
General Catalyst
2 rounds
Sofinnova Investments
1 round
Hillhouse Capital
1 round
Lilly Asia Ventures
2 rounds
OrbiMed
2 rounds
Octagon Capital Advisors
2 rounds
Boyu Capital
2 rounds
Zoo Capital
2 rounds
Sirona Capital
1 round
Catalio Capital Management
1 round
HBM Healthcare Investments
1 round
Shanghai Healthcare Capital
1 round
Sequoia Capital
1 round
Eli Lilly
1 round
Lyra Ventures
1 round
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arrivent"><img src="https://indexed.vc/api/badge/company/arrivent" alt="ArriVent on Indexed.vc" width="260" height="76" /></a>